Relapse · Participants with Crohn's disease in remission
It is very uncertain whether enteral nutrition changes relapse compared with 6‐MP (very low certainty).
1 finding from 1 review
Change in weight (kg) · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in height · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in quality of life · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Participants with Crohn's disease in remission
Enteral nutrition showed no clear difference in adverse events compared with 6‐MP (low certainty).
1 finding from 1 review
Serious adverse events · Participants with Crohn's disease in remission
1 finding from 1 review
Withdrawals due to adverse events · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · Participants with Crohn's disease in remission
Enteral nutrition showed no clear difference in relapse compared with mesalamine (low certainty).
1 finding from 1 review
Change in weight (kg) · Participants with Crohn's disease in remission
1 finding from 1 review
Change in height · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in quality of life · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · patients with acute pancreatitis
Enteral nutrition may leads to lower all‐cause mortality compared with no intervention (low certainty).
1 finding from 1 review
Systemic inflammatory response syndrome · patients with acute pancreatitis
It is very uncertain whether enteral nutrition changes systemic inflammatory response syndrome compared with no intervention (very low certainty).
1 finding from 1 review
Organ failure · patients with acute pancreatitis
It is very uncertain whether enteral nutrition changes organ failure compared with no intervention (very low certainty).
1 finding from 1 review
Adverse events · patients with acute pancreatitis
It is very uncertain whether enteral nutrition changes adverse events compared with no intervention (very low certainty).
1 finding from 1 review
Length of hospital stay · critically ill adult patients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of mechanical ventilation · critically ill adult patients
1 finding from 1 review